Impact of different dose prescription schedules on EQD(2) in high-dose-rate intracavitary brachytherapy of carcinoma cervix

不同剂量处方方案对宫颈癌高剂量率腔内近距离放射治疗中EQD(2)的影响

阅读:1

Abstract

PURPOSE: To observe the effect of different high-dose-rate (HDR) intracavitary brachytherapy dose schedules on equieffective dose in 2 Gy per fraction (EQD(2)). MATERIAL AND METHODS: It is a retrospective study involving 50 cervical cancer patients, who received external radiotherapy of 45 Gy in 25 fractions and underwent intracavitary brachytherapy (ICBT). Computed tomography (CT) simulation was done after insertion of the applicators. High-risk clinical target volume (CTVHR) and organs at risk (OARs) such as bladder, rectum, and sigmoid were contoured. Four different plans were generated for each patient, with dose prescriptions of 5.5 Gy × 5 fractions (plan A), 6.5 Gy × 4 fractions (plan B), 7 Gy × 4 fractions (plan C), and 9 Gy × 2 fractions (plan D), delivered to CTV(HR). The total EQD(2) for 0.1 cm(3) and 2 cm(3) of bladder, rectum, and sigmoid as well as dose received by 90% of the CTV(HR) (D(90)) and point A were calculated. The values were analyzed and compared with available literature. RESULTS: The mean CTV(HR) volume was 47.12 ±13.8 cm(3). All plans delivered similar EQD(2) for 0.1 cm(3) and 2 cm(3) of sigmoid. Plan D delivered lesser EQD(2) compared to other plans for bladder, rectum, D(90) CTVHR, and point A (p = 0.0001). Plan C delivered higher EQD(2) to OARs compared to other plans (p = 0.001). Plan A, B, and plan C delivered similar EQD(2) for D(90) CTV(HR) and point A. CONCLUSIONS: EQD(2) of bladder, rectum, sigmoid, D(90) CTV(HR), and point A were similar with 5.5 Gy × 5 fractions, 6.5 Gy × 4 fractions, and 7 Gy × 4 fractions, whereas EQD(2) of 9 Gy × 2 fractions was significantly unfavorable compared to other schedules. Further clinical studies are recommended to observe clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。